Streptozotocin-Induced Diabetic Cynomolgus Monkey Is a Model of Hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol
スポンサーリンク
概要
- 論文の詳細を見る
Hypertriglyceridemia with low high-density lipoprotein (HDL) cholesterol is a risk factor of cardiovascular disease. We attempted to create an animal model of hypertriglyceridemia with low HDL cholesterol by intravenously injecting 30 mg/kg body weight streptozotocin (STZ) to cynomolgus monkeys. This induced hypoinsulinemia and resulted in a decrease in postheparin plasma lipoprotein lipase (LPL) activity and LPL enzyme mass, reduction of plasma HDL cholesterol and elevation of triglycerides. Low HDL cholesterol subsequently caused a reduction of HDL_<2b> cholesterol, while hypertriglyceridemia caused an elevation of very low-density lipoprotein (VLDL) triglyceridemia. Apolipoprotein CII, a co-factor of LPL, was not affected by STZ administration. These results show that hypertriglyceridemia with low HDL cholesterol results from a reduction of LPL activity without affecting apolipoprotein CII after STZ administration. The STZ-induced diabetic cynomolgus monkey is a model of hypertriglyceridemia with low HDL cholesterol, and may be potentially beneficial for studying atherosclerosis caused by hypertriglyceridemia with low HDL cholesterol.
- 公益社団法人日本薬学会の論文
- 1998-07-15
著者
-
KOHRI Hideaki
Nutrition Research Institute, Otsuka Pharmaceutical Factory, Inc.,
-
Kohri Hideaki
Nutrition Research Institute Otsuka Pharmaceutical Factory Inc.
-
Kohri Hideaki
大塚製薬
-
Kohri Hideaki
Pharmacology Section Nutrition Research Institute Otsuka Pharmaceutical Factory Inc.
-
Kohri H
Otsuka Pharmaceutical Factory Inc. Tokushima Jpn
-
Iwamoto Takeshi
Nutrition Research Institute Otsuka Pharmaceutical Factory Inc.
-
Hagi Akifumi
Nutrition Research Institute Otsuka Pharmaceutical Factory Inc.
-
Hagi Akifumi
徳島大学医学部
-
TSUTSUMI Kazuhiko
Nutrition Research Institute, Otsuka Pharmaceutical Factory Inc.,
-
Tsutsumi K
Otsuka Pharmaceutical Fac. Inc. Tokushima Jpn
-
Iwamoto Takeshi
Nutrition Research Institute, Otsuka Pharmaceutical Factory Inc.,
関連論文
- Amitriptyline-Induced Constipation in Cynomolgus Monkeys Is Beneficial for the Evaluation of Laxative Efficacy
- Practical Debittering Using Model Peptides and Related Compounds(Food & Nutrition)
- Edge Recording on Direct Overwrite Exchange-Coupled Multilayer Media : Media
- Activation of G-protein fMLP or PAF receptor directly triggers glucose transporter type1 (GLUT1) translocation in Chinese hamster ovary (CHO) cells stably expressing fMLP or PAF receptor
- The Relationship between plasma High Density Lipoprotein Cholesterol Levels and Cholesteryl Ester Transfer Protein Activity in Six Species of Healthy Experimental Animals
- Streptozotocin-Induced Diabetic Cynomolgus Monkey Is a Model of Hypertriglyceridemia with Low High-Density Lipoprotein Cholesterol
- The Novel Compound NO-1886 Activates Lipoprotein Lipase in Primary Cultured Adipose and Skeletal Muscle Cells
- Exercise Improved Accumulation of Visceral Fat and Simultaneously Impaired Endothelium-Dependent Relaxation in Old Rats
- X-ray Topographic Observation of Lattice Defects in Heat-Treated SrTiO^3 Crystals
- A Novel Analgesic Compound OT-7100 Attenuates Nociceptive Responses in Animal Models of Inflammatory and Neuropathic Hyperaralgesia: A Possible Involvement of Adenosinergic Anti-nociception
- Synthesis and Biological Activity of the Metabolites of Diethyl 4-[(4-Bromo-2-cyanophenyl)carbamoyl]benzylphosphonate (NO-1886)
- The Novel Analgesic Compound OT-7100 (5-n-Butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimidine) Attenuates Mechanical Nociceptive Responses in Animal Models of Acute and Peripheral Neuropathic Hyperalgesia
- Suppression of Hyperlipidemia-Associated Cataracts in Diabetic Rats with the Lipoprotein Lipase Activator NO-1886
- Acceleration of Development of Diabetic Cataract by Hyperlipidemia and Low High-Density Lipoprotein in Rats
- A New Direct Overwrite Method by Light Intensity Modulation with Multi Layered Magneto-Optical Discs